User profiles for Hendrik Johannes Harms

HJ Harms

Verified email at clin.au.dk
Cited by 2870

Cardiovascular effects of treatment with the ketone body 3-hydroxybutyrate in chronic heart failure patients

…, LP Tolbod, NH Hansson, J Sorensen, HJ Harms… - Circulation, 2019 - Am Heart Assoc
Background: Myocardial utilization of 3-hydroxybutyrate (3-OHB) is increased in patients with
heart failure and reduced ejection fraction (HFrEF). However, the cardiovascular effects of …

Ketone body infusion with 3‐hydroxybutyrate reduces myocardial glucose uptake and increases blood flow in humans: a positron emission tomography study

…, N Christensen, LP Tolbod, HJ Harms… - Journal of the …, 2017 - Am Heart Assoc
Background High levels of ketone bodies are associated with improved survival as observed
with regular exercise, caloric restriction, and—most recently—treatment with sodium–…

A randomised, double‐blind, placebo‐controlled trial of metformin on myocardial efficiency in insulin‐resistant chronic heart failure patients without diabetes

…, H Nørrelund, LP Tolbod, HJ Harms… - European journal of …, 2020 - Wiley Online Library
Aims The present study tested the hypothesis that metformin treatment may increase
myocardial efficiency (stroke work/myocardial oxygen consumption) in insulin‐resistant patients …

Myocardial efficiency: a fundamental physiological concept on the verge of clinical impact

J Sörensen, HJ Harms, JM Aalen, T Baron… - Cardiovascular …, 2020 - jacc.org
Myocardial external efficiency is the relation of mechanical energy generated by the left (or
right) ventricle to the consumed chemical energy from aerobic metabolism. Efficiency can be …

Heart failure patients with prediabetes and newly diagnosed diabetes display abnormalities in myocardial metabolism

…, K Bouchelouche, J Sørensen, HJ Harms… - Journal of Nuclear …, 2018 - Springer
Background In type 2 diabetes, a decrease in myocardial glucose uptake (MGU) may lower
glucose oxidation and contribute to progression of chronic heart failure (CHF). However, it is …

Metoprolol reduces hemodynamic and metabolic overload in asymptomatic aortic valve stenosis patients: a randomized trial

NH Hansson, J Sörensen, HJ Harms… - Circulation …, 2017 - Am Heart Assoc
Background— Currently, no pharmacological treatment can modify the natural history of aortic
valve stenosis (AS). This underlines the critical need to explore novel treatment strategies, …

Myocardial oxygen consumption and efficiency in aortic valve stenosis patients with and without heart failure

NHS Hansson, J Sörensen, HJ Harms… - Journal of the …, 2017 - Am Heart Assoc
Background Myocardial oxygen consumption (MVO 2 ) and its coupling to contractile work
are fundamentals of cardiac function and may be involved causally in the transition from …

Effect of liraglutide on myocardial glucose uptake and blood flow in stable chronic heart failure patients: a double-blind, randomized, placebo-controlled LIVE sub …

…, K Bouchelouche, J Sørensen, HJ Harms… - Journal of Nuclear …, 2019 - Elsevier
Background The glucagon-like peptide-1 analog liraglutide increases heart rate and may
be associated with more cardiac events in chronic heart failure (CHF) patients. We studied …

Myocardial efficiency in patients with different aetiologies and stages of heart failure

…, LP Tolbod, LC Gormsen, HJ Harms… - European Heart …, 2022 - academic.oup.com
Aims Myocardial external efficiency (MEE) is the ratio of cardiac work in relation with energy
expenditure. We studied MEE in patients with different aetiologies and stages of heart failure …

[HTML][HTML] Automatic extraction of forward stroke volume using dynamic PET/CT: a dual-tracer and dual-scanner validation in patients with heart valve disease

HJ Harms, LP Tolbod, NHS Hansson, T Kero… - EJNMMI physics, 2015 - Springer
Background The aim of this study was to develop and validate an automated method for
extracting forward stroke volume (FSV) using indicator dilution theory directly from dynamic …